Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Frequency Therapeutics Inc (FREQ)

Frequency Therapeutics Inc (FREQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, DEN, PRDS, FREQ PR Newswire - Mon Aug 7, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PRDS : 2.16 (unch)
AEL : 56.47 (+0.55%)
FREQ : 0.2996 (+5.94%)
DEN : 88.66 (-0.26%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AJX, DEN, FREQ, NLTX PR Newswire - Tue Aug 1, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NLTX : 3.49 (+1.45%)
FREQ : 0.2996 (+5.94%)
DEN : 88.66 (-0.26%)
AJX : 3.02 (-0.66%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAIC, BG, DEN, FREQ PR Newswire - Wed Jul 26, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AAIC : 4.84 (+1.47%)
BG : 128.32 (+0.88%)
FREQ : 0.2996 (+5.94%)
DEN : 88.66 (-0.26%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DEN, NLTX, FREQ PR Newswire - Tue Jul 18, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NLTX : 3.49 (+1.45%)
FREQ : 0.2996 (+5.94%)
DEN : 88.66 (-0.26%)
Frequency Therapeutics Provides Business Updates and Fourth Quarter and Full Year 2022 Financial Results Business Wire - Fri Mar 10, 2023

Frequency Therapeutics, Inc. (Nasdaq: FREQ), a regenerative medicine company focused on developing therapeutics to activate a person’s innate potential to restore function, today announced business updates...

FREQ : 0.2996 (+5.94%)
Frequency Therapeutics to Participate at Upcoming March Investor Conferences Business Wire - Mon Feb 27, 2023

Frequency Therapeutics, Inc. (Nasdaq: FREQ), a regenerative medicine company focused on developing therapeutics to activate a person’s innate potential to restore function, today announced that interim...

FREQ : 0.2996 (+5.94%)
Frequency Therapeutics Announces Topline Results for its Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss Business Wire - Mon Feb 13, 2023

Frequency Therapeutics, Inc. (Nasdaq: FREQ), a regenerative medicine company focused on developing therapeutics to activate a person’s innate potential to restore function, today announced clinical results...

FREQ : 0.2996 (+5.94%)
Frequency Therapeutics Announces Formation of Clinical Advisory Board for Remyelination in Multiple Sclerosis Program Business Wire - Mon Dec 19, 2022

Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person’s innate potential to restore function, today announced...

FREQ : 0.2996 (+5.94%)
Frequency Therapeutics Announces First Patient Dosed in Phase 1b Study of FX-345, the Company’s Second Therapeutic Candidate for Sensorineural Hearing Loss Business Wire - Thu Dec 15, 2022

Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person’s innate potential to restore function, today announced...

FREQ : 0.2996 (+5.94%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Frequency Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors PR Newswire - Tue Nov 29, 2022

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

FREQ : 0.2996 (+5.94%)

Barchart Exclusives

This Dividend Stock Has Been Steady Amid the Iran War: Is It Still a Buy? Barchart - Wed Apr 1, 6:30PM CDT
Citigroup has a dividend yield of over 2.2% and has outperformed the markets over the last month. Is the stock still a buy? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.